Effectiveness of rotavirus vaccine in preventing severe acute gastroenteritis in children

Canadian Family Physician

Volumn 58, Issue 3, 2012, Pages 270-271

  Goldman, Ran D ^a  

^a PRETx Program   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; DEHYDRATION; DEVELOPING COUNTRY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; HOSPITALIZATION; HUMAN; IMMUNIZATION; MORBIDITY; MORTALITY; PEDIATRICS; ROTAVIRUS INFECTION; SHORT SURVEY;

ACUTE DISEASE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INFANT; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEVERITY OF ILLNESS INDEX;

EID: 84858305131     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (22)

1. King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003;52(RR-16):1-16.
2. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003;81(3):197-204. Epub 2003 May 16.
3. King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003;52(RR-16):1-16.
4. Nutrition Committee, Canadian Paediatric Society. Oral rehydration therapy and early refeeding in the management of childhood gastroenteritis. Paediatr Child Health (Oxford) 2006;11(8):527-31.
5. Salvadori M, Le Saux N. Recommendations for the use of rotavirus vaccines in infants. Paediatr Child Health (Oxford) 2010;15(8):519-28.
6. Jacobs P, Shane L, Fassbender K, Wang E, Moineddin R, Ford-Jones E. Economic analysis of rotavirus-associated diarrhea in the metropolitan Toronto and Peel regions of Ontario. Can J Infect Dis Med Microbiol 2002;13(3):167-74. (Pubitemid 34855525)
7. Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med 2000;154(6):578-85.
8. National Advisory Committee on Immunization (NACI). Updated statement on the use of rotavirus vaccines. Can Commun Dis Rep 2010;36(ACS-4):1-37. Available from: www.phac-aspc.gc.ca/publicat/ccdr-rmtc/10vol36/ acs-4/index-eng.php. Accessed 2012 Jan 27.
9. Dennehy PH. Effects of vaccine on rotavirus disease in the pediatric population. Curr Opin Pediatr 2012;24(1):76-84.
10. Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008;371(9691):1181-9. (Pubitemid 351458523)
11. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354(1):23-33. (Pubitemid 43048948)
12. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007;370(9601):1757-63. (Pubitemid 350137490)
13. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo controlled trial. Lancet 2010;376(9741):606- 14. Epub 010 Aug 6.
14. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebocontrolled trial. Lancet 2010;376(9741):615-23. Epub 2010 Aug 6.
15. Muhsen K, Chodick G, Goren S, Shalev V, Cohen D. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community. Vaccine 2010;29(1):91-4. Epub 2010 Oct 20.
16. Muhsen K, Shulman L, Kasem E, Rubinstein U, Shachter J, Kremer A, et al. Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritisassociated hospitalizations in Israel: a case-control study. Hum Vaccin 2010;6(6):450-4. Epub 2010 Jun 1.
17. Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010;126(3):e506-12. Epub 2010 Aug 23.
18. Mast TC, Khawaja S, Espinoza F, Paniagua M, Del Carmen LP, Cardellino A, et al. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua. Pediatr Infect Dis J 2011;30(11):e209-15.
19. Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010;125(2):e199-207. Epub 2010 Jan 18.
20. Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, et al. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J 2010;29(12):1133-5.
21. Desai SN, Esposito DB, Shapiro ED, Dennehy PH, Vázquez M. Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA. Vaccine 2010;28(47):7501-6. Epub 2010 Sep 17.
22. Staat MA, Payne DC, Donauer S, Weinberg GA, Edwards KM, Szilagyi PG, et al. Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics 2011;128(2):e267-75. Epub 2011 Jul 18.